12 September 2025 in Seminars in Ophthalmology
Keratoconus (KC) is a progressive corneal disorder characterized by thinning and conical protrusion, leading to visual impairment. Whereas traditionally viewed as non-inflammatory, recent evidence highlights the role of chronic inflammation, oxidative stress, and genetic susceptibility in its pathogenesis. A literature review was conducted using PubMed, Embase, and Scopus databases focusing on keratoconus etiology and risk factors. The most significant factors include eye rubbing, male sex, time spent using computers after work or school, and exposure to dust or particulates in the workplace. Additionally contributors include environmental factors (UV exposure, air pollution) and systemic conditions (connective tissue disorders, autoimmune diseases). Developing research also ensnares lifestyle factors such as poor nutrition, sleep disruption, and psychological stress in disease progression. Advances in genetic and epigenetic studies uncover dysregulation in corneal structure and repair mechanisms, while microbiome imbalances may further exacerbate inflammation. This review synthesizes current knowledge on KC's multifactorial etiology, emphasizing the shift toward holistic management strategies that address both ocular and systemic factors. Environmental exposures, daily habits, and systemic health converge to influence keratoconus onset and progression for understanding this enigmatic disease. Future directions include personalized therapies focusing on fundamental molecular pathways and public health measures to moderate environmental risks.
20 August 2025 in International Journal of Innovative Technologies in Social Science
Dry eye disease (DED), characterized by unstable tear film and damage to the eye's surface, is becoming more common because of environmental and lifestyle factors. Conventional treatments often don’t fix the problems of oxidative stress and inflammation that cause it. This has led to interest in natural antioxidants like matcha, a type of green tea powder grown in the shade. Unlike conventional green tea, matcha contains higher concentrations of polyphenols, particularly epigallocatechin gallate (EGCG). These polyphenols have strong antioxidant and anti-inflammatory effects. This review explores matcha’s potential in preventing DED by analyzing its mechanisms of action, such as by removing reactive oxygen species (ROS) and increasing endogenous antioxidants (e.g., superoxide dismutase). It also looks at how matcha reduces pro-inflammatory cytokines (e.g., TNF-α, IL-6) through the NF-κB and MAPK pathways. The discussion also covers matcha’s effects on tear film stability through enhanced mucin secretion and meibomian gland function. Studies show that green tea polyphenols can improve tear production and reduce corneal staining, though matcha-specific studies remain limited. New research shows that it has systemic benefits, including modulation of gut microbiota, which may indirectly support ocular health. Challenges include optimizing dosage and delivery methods, but matcha’s bioavailability and ability to act on many targets make it a potentially helpful additional treatment. More clinical trials are needed to prove its efficacy. However, current information suggests it could help with the many factors that cause DED by balancing redox and reducing inflammation.
24 September 2025 in International Journal of Innovative Technologies in Social Science
Background: Research on social functioning difficulties in individuals with bipolar disorder has produced inconsistent findings, ranging from significant social impairments to no differences or even superior outcomes compared to patients with depression. Current literature is limited by methodological constraints including use of non-validated self-report measures, lack of analysis of specific support sources, and absence of appropriate clinical comparison groups. These contradictory results necessitate investigation of alternative variables that may explain social support variations in affective disorders, which is crucial for developing targeted psychosocial interventions for bipolar disorder populations. Methods: A quasi-experimental study recruited 89 participants (52 bipolar disorder, 37 depression) from online support groups across Polish, English, and Spanish-speaking populations. Perceived social support was measured using the Multidimensional Scale of Perceived Social Support (MSPSS). ANCOVA models controlled for age, gender, and psychiatric comorbidity. Results: No significant differences emerged between diagnostic groups after controlling for covariates (p > .05). However, age was negatively correlated with global support (p = .021), friends support (r = −.28, p < .007), and significant other support (r = −.23, p = .028), while family support remained stable (r = −.06, p = .555). Both groups scored substantially below Polish population norms with large effect sizes (bipolar disorder: d = −1.11; depression: d = −1.29; p < .001). Conclusions: Age, rather than diagnostic category, predicts perceived social support decline in affective disorders. Both groups demonstrate clinically meaningful social support deficits, suggesting common vulnerabilities requiring targeted interventions across affective disorder spectrum.